Suppr超能文献

Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression.

作者信息

Levy N, Yonish-Rouach E, Oren M, Kimchi A

机构信息

Department of Molecular Genetics and Virology, Weizmann Institute of Science, Rehovot, Israel.

出版信息

Mol Cell Biol. 1993 Dec;13(12):7942-52. doi: 10.1128/mcb.13.12.7942-7952.1993.

Abstract

Stable transfection of M1 myeloid leukemia cells with a temperature-sensitive mutant of p53 results in two phenomena that are manifested exclusively at the permissive temperature. On one hand, activation of wild-type p53 by the temperature shift induced an apoptotic type of cell death which could be inhibited by interleukin-6 (IL-6) (E. Yonish-Rouach, D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren, Nature 352:345-347, 1991). On the other hand, as reported in this work, activated p53 complemented the antiproliferative effects of IL-6 in M1 cells. A shift to the permissive temperature concomitant with or early after IL-6 treatment imposed a novel pattern of cell cycle arrest in which about 95% of the cells were retained within a G0-like quiescent state. This phase was characterized by 2N DNA content and low RNA and protein content. On the molecular level, activation of wild-type p53 transrepressed the c-myc gene but not the cyclin A, D1, or D2 gene, which are all independently suppressed by IL-6 in M1 cells. To further analyze whether c-myc inhibition mediates or complements p53 effects, the p53-transfected M1 cells were infected with a retroviral vector expressing deregulated c-myc, refractory to p53 or IL-6 action. It was found that the process of cell death was not interrupted at all in these M1 c-myc-p53 double transfectants, suggesting that the transrepression of c-myc is not a major obligatory event mediating p53-induced cell death. In addition, some of the antiproliferative effects of activated p53, manifested in the presence of IL-6, could still be transmitted in the background of constitutive c-myc. Yet the context of deregulated c-myc interfered with the final accumulation of cells within a G0-like phase, suggesting complementary interactions between the outcome of p53 activation and of c-myc suppression in the control of cell cycle arrest.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a44/364866/f775a935ca08/molcellb00024-0758-a.jpg

相似文献

2
p53-mediated cell death: relationship to cell cycle control.
Mol Cell Biol. 1993 Mar;13(3):1415-23. doi: 10.1128/mcb.13.3.1415-1423.1993.
8
A mutant p53 antagonizes the deregulated c-myc-mediated enhancement of apoptosis and decrease in leukemogenicity.
Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9672-6. doi: 10.1073/pnas.92.21.9672.
9
p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
Oncogene. 2000 Jun 15;19(26):2967-77. doi: 10.1038/sj.onc.1203638.

引用本文的文献

1
PTEN loss drives p53 LOH and immune evasion in a novel urothelial organoid model harboring p53 missense mutations.
Oncogene. 2025 May;44(19):1336-1349. doi: 10.1038/s41388-025-03311-5. Epub 2025 Feb 22.
3
Metabolic Rewiring and Stemness: A Critical Attribute of Pancreatic Cancer Progression.
Stem Cells. 2023 May 15;41(5):417-430. doi: 10.1093/stmcls/sxad017.
4
Deciphering the Role of p53 and TAp73 in Neuroblastoma: From Pathogenesis to Treatment.
Cancers (Basel). 2022 Dec 16;14(24):6212. doi: 10.3390/cancers14246212.
5
Metastatic pancreatic neuroendocrine tumors feature elevated T cell infiltration.
JCI Insight. 2022 Dec 8;7(23):e160130. doi: 10.1172/jci.insight.160130.
6
AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer.
Mol Cancer Ther. 2022 Jan;21(1):38-47. doi: 10.1158/1535-7163.MCT-21-0293. Epub 2021 Oct 21.
7
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.
J Hematol Oncol. 2021 Aug 9;14(1):121. doi: 10.1186/s13045-021-01111-4.
8
Immune Subtypes Based on Immune-Related lncRNA: Differential Prognostic Mechanism of Pancreatic Cancer.
Front Cell Dev Biol. 2021 Jul 7;9:698296. doi: 10.3389/fcell.2021.698296. eCollection 2021.
10
Gene Transactivation and Transrepression in MYC-Driven Cancers.
Int J Mol Sci. 2021 Mar 27;22(7):3458. doi: 10.3390/ijms22073458.

本文引用的文献

2
p53-mediated cell death: relationship to cell cycle control.
Mol Cell Biol. 1993 Mar;13(3):1415-23. doi: 10.1128/mcb.13.3.1415-1423.1993.
3
mdm2 expression is induced by wild type p53 activity.
EMBO J. 1993 Feb;12(2):461-8. doi: 10.1002/j.1460-2075.1993.tb05678.x.
4
Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells.
Mol Cell Biol. 1993 Jan;13(1):711-9. doi: 10.1128/mcb.13.1.711-719.1993.
6
Cell heterogeneity during the cell cycle.
J Cell Physiol. 1982 Dec;113(3):465-74. doi: 10.1002/jcp.1041130316.
7
Subcompartments of the G1 phase of cell cycle detected by flow cytometry.
Proc Natl Acad Sci U S A. 1980 Nov;77(11):6696-9. doi: 10.1073/pnas.77.11.6696.
8
Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.
Mol Cell Biol. 1985 Dec;5(12):3610-6. doi: 10.1128/mcb.5.12.3610-3616.1985.
9
Close link between reduction of c-myc expression by interferon and, G0/G1 arrest.
Nature. 1985;313(6003):597-600. doi: 10.1038/313597a0.
10
Tumor necrosis factor reduces c-myc expression and cooperates with interferon-gamma in HeLa cells.
Science. 1986 Dec 12;234(4782):1419-21. doi: 10.1126/science.3097823.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验